Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Lymphoma, Follicular 6Lymphoma 6Multiple Myeloma 4Neoplasms, Plasma Cell 3Leukemia, Myeloid, Acute 3Waldenstrom Macroglobulinemia 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Myelodysplastic Syndromes 2Melanoma 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia 2Kidney Neoplasms 2Immunoglobulin Light-chain Amyloidosis 2Carcinoma, Renal Cell 2Burkitt Lymphoma 2Breast Neoplasms 2Unspecified Childhood Solid Tumor, Protocol Specific 1Thrombocythemia, Essential 1Squamous Cell Carcinoma of Head and Neck 1Smoldering Multiple Myeloma 1Rectal Neoplasms 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Polycythemia Vera 1

Interventions

Tretinoin 11Arsenic Trioxide 7Idarubicin 4Mitoxantrone 3Etoposide 3Daunorubicin 3Cytarabine 3Thioguanine 2Radiotherapy 2Cyclophosphamide 2sargramostim 1Watchful Waiting 1Peripheral Blood Stem Cell Transplantation 1Methotrexate 1Mercaptopurine 1Hydroxyurea 1Filgrastim 1Busulfan 1Bortezomib 1Ascorbic Acid 1Amsacrine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Leukemia, Promyelocytic, Acute × sargramostim × Clear all
NCT00454168 2014-01-06

Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in Remission

National Cancer Institute (NCI)

Phase 3 Unknown
244 enrolled
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡